NASDAQ:NVCN - Neovasc Stock Price, Forecast & News

Neovasc's stock was trading at $2.21 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NVCN shares have decreased by 33.9% and is now trading at $1.46. View which stocks have been mosted impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neovasc.

Neovasc Inc (NASDAQ:NVCN) issued its earnings results on Monday, March, 30th. The medical equipment provider reported ($1.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by $0.82. View Neovasc's earnings history.

Neovasc's stock reverse split on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

2 brokers have issued 12-month target prices for Neovasc's stock. Their forecasts range from $3.00 to $9.00. On average, they expect Neovasc's share price to reach $6.00 in the next year. This suggests a possible upside of 311.0% from the stock's current price. View analysts' price targets for Neovasc.

Headlines about NVCN stock have been trending very negative on Wednesday, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Neovasc earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutNeovasc.

Neovasc saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 221,800 shares, an increase of 20.9% from the February 27th total of 183,500 shares. Based on an average daily trading volume, of 92,500 shares, the short-interest ratio is currently 2.4 days. Currently, 2.4% of the shares of the stock are sold short. View Neovasc's Current Options Chain.

Some companies that are related to Neovasc include PAVmed (PAVM), SANUWAVE Health (SNWV), Pro-Dex (PDEX), Nephros (NEPH), Nephros (NEPHD), Apollo Endosurgery (APEN), Arch Therapeutics (ARTH), Sensus Healthcare (SRTS), Biostage (BSTG), Invo Bioscience (IVOB), Delcath Systems (DCTH), STRATA Skin Sciences (SSKN), T2 Biosystems (TTOO), Neuronetics (STIM) and DarioHealth (DRIO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), Rexahn Pharmaceuticals (REXN), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP), Micron Technology (MU), Protalix Biotherapeutics (PLX), 22nd Century Group (XXII), Advanced Micro Devices (AMD) and Corbus Pharmaceuticals (CRBP).

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NVCN stock can currently be purchased for approximately $1.46.

Neovasc has a market capitalization of $16.25 million and generates $1.75 million in revenue each year. The medical equipment provider earns $-108,040,000.00 in net income (profit) each year or ($27.30) on an earnings per share basis. Neovasc employs 98 workers across the globe. View additional information about Neovasc.

The official website for Neovasc is http://www.neovasc.com/.

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]